Cargando…
Imatinib prevents beta cell death in vitro but does not improve islet transplantation outcome
Introduction Improving islet transplantation outcome could not only bring benefits to individual patients but also widen the patient pool to which this life-changing treatment is available. Imatinib has previously been shown to protect beta cells from apoptosis in a variety of in vitro and in vivo m...
Autores principales: | King, Aileen J. F., Griffiths, Lisa A., Persaud, Shanta J., Jones, Peter M., Howell, Simon L., Welsh, Nils |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900069/ https://www.ncbi.nlm.nih.gov/pubmed/26953716 http://dx.doi.org/10.3109/03009734.2016.1151090 |
Ejemplares similares
-
Effects of Imatinib Mesylate (Gleevec) on Human Islet NF-kappaB Activation and Chemokine Production In Vitro
por: Mokhtari, Dariush, et al.
Publicado: (2011) -
Somatostatin Secreted by Islet δ-Cells Fulfills Multiple Roles as a Paracrine Regulator of Islet Function
por: Hauge-Evans, Astrid C., et al.
Publicado: (2009) -
Are off-target effects of imatinib the key to improving beta-cell function in diabetes?
por: Welsh, Nils
Publicado: (2022) -
Maintenance of Islet Morphology Is Beneficial for Transplantation Outcome in Diabetic Mice
por: Rackham, Chloe L., et al.
Publicado: (2013) -
Using Mesenchymal Stromal Cells in Islet Transplantation
por: Arzouni, Ahmed A., et al.
Publicado: (2018)